Drugmakers and pharmacists battle over who gets to make obesity drugs
(By Sydney Lupkin for NPR) Ozempic and similar drugs for Type 2 diabetes and weight loss are in such high
Read More(By Sydney Lupkin for NPR) Ozempic and similar drugs for Type 2 diabetes and weight loss are in such high
Read More(By Sydney Lupkin for NPR) Can the National Institutes of Health bring down drug prices? It doesn’t approve new medicines
Read More(By Arthur Allen for KFF Health News) Under the leadership of an aggressive opponent of anti-competitive business practices, the Federal
Read More(Leslie Walker and Dan Gorenstein for NPR) Medicare’s historic plan to slow prescription drug spending is taking shape. Thursday federal
Read More